W. Majewski et M. Iskra, Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs, INT J CL L, 29(2), 1999, pp. 64-67
Citations number
16
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
Cu,Zn-superoxide dismutase is an endogenous scavanger of superoxide radical
s (O-2(-)) which also induce the synthesis of this enzyme. Ceruloplasmin is
an antioxidant and acute-phase reactant. Changes in the synthesis of both
enzymes are related to the metabolism of copper and zinc. Concentrations of
copper and zinc were previously found to be increased in the serum and art
erial wall of atherosclerotic subjects. The aim of this study was to invest
igate the Cu,Zn-superoxide dismutase activity in erythrocytes and cerulopla
smin activity in serum, and to measure serum concentrations of copper, zinc
, and malonyldialdehyde in patients with moderate and critical chronic isch
emia of the lower limbs. A group of 26 patients with chronic arterial occlu
sion of the lower limbs was divided into two groups depending on the degree
of ischemia: moderate and critical. Cu,Zn-superoxide dismutase activity in
erythrocytes was measured using the RANSOD kit, the serum ceruloplasmin ox
idase activity was determined with o-dianisidine as a substrate. Copper and
zinc concentrations in serum were determined by atomic absorption spectrom
etry. There was an increase in the ceruloplasmin activity and serum copper
concentration in critical ischemia (194.4+/-51.94 U/l and 23.5+/-4.2 mu mol
/l, respectively) compared with moderate ischemia (139.1+/-34.9 U/l and 18.
5+/-2.0 mu mol/l, respectively). The Cu,Zn-superoxide dismutase activity in
erythrocytes was higher in moderate ischemia (2,657+/-1,564 U/g hemoglobin
) than in controls (1,205+/-353 U/g hemoglobin), but not different from cri
tical ischemia. There was a negative correlation for Cu,Zn-su-peroxide dism
utase and ceruloplasmin (r=-0.60, P less than or equal to 0.05) in critical
ischemia.